The PRIMO study: A phase 2 study of duvelisib efficacy and safety in patients with relapsed or refractory peripheral t-cell lymphoma (PTCL) Meeting Abstract


Authors: Horwitz, S. M.; Soto, J.; Youssoufian, H.; Lloyd, D.; Le, N. T.
Abstract Title: The PRIMO study: A phase 2 study of duvelisib efficacy and safety in patients with relapsed or refractory peripheral t-cell lymphoma (PTCL)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 422s
Language: English
ACCESSION: WOS:000442916007725
DOI: 10.1200/JCO.2018.36.15_suppl.TPS7590
PROVIDER: wos
Notes: Meeting Abstract: TPS7590 -- Source: Wos
Altmetric Score
MSK Authors
  1. Steven M Horwitz
    343 Horwitz
Related MSK Work